• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: March 26-30, 2012

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

March 26-30, 2012
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Counselor to the Commissioner3/27/12Cambridge, MASiobhan DeLanceyMassachusetts Institute of Technology Knight Science Journalism FellowsSpeech on Food Safety Modernization Act
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy3/26/12-3/30/12 N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/28/12Washington, DCN/ASeveral representatives from George Washington University Residency FellowshipTobacco Product Regulation and Public Health
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products3/29/12Washington, DCAmy HertzSeveral representatives from American Legacy FoundationMeet and Greet
Elizabeth H. Dickinson, Esq., Chief Counsel3/28/12Silver Spring, MDAnn WionColeen Klasmeier (Sidley Austin); Kevin Osborne, Denise Keane (Altria Client Services)Tobacco Product Regulations
Elizabeth H. Dickinson, Esq., Chief Counsel3/29/12Silver Spring, MDEric Blumberg; Karen SchifterKathryn Waldman; Mary Elcano (American Red Cross)American Red Cross
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine3/26/12-3/30/12N/AN/AN/ANo Significant Meetings 
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Michael M. Landa, Director, Center for Food Safety and Applied Nutrition3/26/12- 3/30/12N/AN/AN/ANo Significant Meetings
Jim Sigg, Acting Chief Operating Officer3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health3/27/12Silver Spring, MDSteven Silverman, Ann Ferriter, William Maisel, Lawrence Deyton, Eric Lindblom, Shawn Fultz, Benjamin ApelbergNancy Brodsky, Bob Glass,  Steve Verzi,  Steve Kleban,  Theresa Brown (Sandia National Laboratories)Sandia Modeling Project
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products and Tobacco3/29/12Silver Spring, MDJane Axelrad, Lisa Dwyer, Martha NguyenBart Stupak (Venable LLP)Primatene Mist
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods3/27/12Cambridge, MASiobhan DeLanceyMassachusetts Institute of Technology Knight Science Journalism FellowsSpeech on Food Safety Modernization Act
Mary Lou Valdez, Associate Commissioner for International Programs3/29/12Silver Spring, MDFDA Senior StaffInstitute of Medicine (IOM) StaffStrengthening Core Elements of Regulatory Systems in Developing Countries
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs3/26/12-3/30/12N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research3/28/12Washington, DCN/AGillian Woollett (Avalere Health); Joe Selby (PCORI)Avalere Health Event